| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40114fb3c8d4f80649201a3c49d9da8b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10111 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-576
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
2009-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ae429c61f7043e32a782d234b73ff8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6ce6caf15cbd4045f534af7ad3b4708 |
| publicationDate |
2011-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2327778-A1 |
| titleOfInvention |
Nucleic acid occurring in blood from hepatitis patient, polypeptide encoded by the nucleic acid, and use of the same |
| abstract |
A substance associated with cryptogenic hepatitis is found and information, particularly genetic information, on the substance is provided. Also, a method for detecting the substance and a material which can be used in the method are provided. A nucleic acid is extracted from each of 500 blood samples which have alanine aminotransferase (ALT) abnormality and are negative for a hepatitis virus marker, and the amplification of the nucleic acid is carried out by using helicase family-reactive helicase primers which have been produced uniquely. As a result, a novel nucleotide sequence (SEQ ID NO:1) can be obtained, and it is found that the nucleotide sequence occurs at high frequency in cryptogenic hepatitis. |
| priorityDate |
2008-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |